Your browser doesn't support javascript.
loading
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
Arouche, Tiago da Silva; Martins, Anderson Yuri; Ramalho, Teodorico de Castro; Júnior, Raul Nunes Carvalho; Costa, Fabio Luiz Paranhos; Filho, Tarciso Silva de Andrade; Neto, Antonio Maia Jesus Chaves.
Afiliação
  • Arouche TDS; Laboratory of Preparation and Computation of Nanomaterials (LPCN), Federal University of Pará, C. P. 479, 66075-110 Belem, PA, Brazil.
  • Martins AY; Laboratory of Preparation and Computation of Nanomaterials (LPCN), Federal University of Pará, C. P. 479, 66075-110 Belem, PA, Brazil.
  • Ramalho TC; Federal University of Lavras (UFLA), Chemistry Department, 37200-000 - Lavras, MG, Brazil.
  • Júnior RNC; Post-Graduation Program in Engineering of Natural Resources of the Amazon, Institute of Technology (ITEC), Federal University of Pará, C. P. 2626, 66.050-540, Belem, PA, Brazil.
  • Costa FLP; Universidade Federal de Jataí. Rodovia BR-364, 75.8016-15 - Jataí, GO - Brazil.
  • Filho TSA; Federal University of the South and Southeast of Pará. FL 17, QD 04, LT Especial, New Marabá, 68.505-080 - Marabá, PA - Brazil.
  • Neto AMJC; Laboratory of Preparation and Computation of Nanomaterials (LPCN), Federal University of Pará, C. P. 479, 66075-110 Belem, PA, Brazil.
J Nanosci Nanotechnol ; 21(4): 2075-2089, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33500022

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ivermectina / Heparina / Azitromicina / Ritonavir / Oseltamivir / Lopinavir / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Nanosci Nanotechnol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ivermectina / Heparina / Azitromicina / Ritonavir / Oseltamivir / Lopinavir / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Nanosci Nanotechnol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil